179 related articles for article (PubMed ID: 18941460)
1. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.
Ridolfi E; Matteucci E; Maroni P; Desiderio MA
Br J Cancer; 2008 Nov; 99(10):1623-34. PubMed ID: 18941460
[TBL] [Abstract][Full Text] [Related]
2. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
[TBL] [Abstract][Full Text] [Related]
3. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
[TBL] [Abstract][Full Text] [Related]
4. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.
Maroni P; Bendinelli P; Matteucci E; Desiderio MA
Carcinogenesis; 2007 Feb; 28(2):267-79. PubMed ID: 16840440
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion.
Tu H; Zhou Z; Liang Q; Li Z; Li D; Qing J; Wang H; Zhang L
Onkologie; 2009 Jun; 32(6):331-6. PubMed ID: 19521120
[TBL] [Abstract][Full Text] [Related]
6. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
7. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
9. HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells.
Huang S; Ouyang N; Lin L; Chen L; Wu W; Su F; Yao Y; Yao H
PLoS One; 2012; 7(1):e29124. PubMed ID: 22242160
[TBL] [Abstract][Full Text] [Related]
10. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
[TBL] [Abstract][Full Text] [Related]
11. Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
Zhao M; Mueller BM; DiScipio RG; Schraufstatter IU
Breast Cancer Res Treat; 2008 Jul; 110(2):211-22. PubMed ID: 17687643
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness.
Matteucci E; Locati M; Desiderio MA
Exp Cell Res; 2005 Oct; 310(1):176-85. PubMed ID: 16112111
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
16. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
17. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
20. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]